SlideShare una empresa de Scribd logo
1 de 15
Healthcare in the Netherlands Focussed on hospitals Prague, 25 November 2009
Agenda Introduction Financing health care in the Netherlands Critical succesfactors for implementing a new system Lessons learned Trends and future developments Questions and discussion
Introduction - Current health care costs  How to control health care expenditure in coming years? 13,3% 13,1% 13,1% % GDP in the Netherlands PM 6,3% 6,6% % GDP in The Czech Republic Total health care costs in the Netherlands * = preliminary figures 5,8% 4.809 4.545 4.315 Per person (in Euros) 6,2% 79.091 74.446 70.533 Total 0,4% 2.505 2.494 2.327 Administrative 5,7% 30.204 28.562 27.523 Cure 6,9% 46.382 43.390 40.683 Care ∆   07/08 2008* 2007* 2006 in millions of Euros
Introduction – Healthcare model Cure Voluntary  health care Care ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Dentist, physiotherapy, plastic surgery and alternative care General practitioner, hospitals, ambulance and other lifesaving care Care for disabled people, care of the elderly, home care etc. (Insurance) coverage Kind of care included
Introduction – The objectives of the model ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],The Dutch health care model combines social guarantees  with market incentives
Financing health care in the Netherlands – in general – Health Care providers Health care insurers Risk Equalisation Government Policyholders Hospitals Etc. Employers Contribution Contribution Fees Premiums Personal contributions Tax Allowances Cure Settlements Government compensates for budget overruns
Financing health care in the Netherlands – hospitals  Registration of primary activities and insight into cost prices of products are essential Financing guaranteed by the government Market prices negotiated with health insurance companies Budget based Based on market prices 2004 2020 2012 Parameters related to medical activities Parameters (30,000) based on fee for service model Parameters (3,000) based on fee for service model
Critical succesfactors for implementing a new system ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Keep it simple
Lessons learned ,[object Object],[object Object],[object Object],[object Object],[object Object]
Trends and future developments ,[object Object],[object Object],[object Object],[object Object]
Trends and future developments – Measuring Quality – Distribution of hospitals in terms of ‘quality of care’. The blue mark indicates the percentage of hospitals performing less good than hospital X
University General practitioners Personal health care Elective non-complex care Specialized clinics Process oriented Market prices Basic hospital care Rural hospitals Compliants oriented Performance-related funding Elective very complex care University Medical Centers and large hospitals Process oriented Licensed care and prices Top preference care University Medical Centers Disease oriented Performance-related funding   and an academic surcharge Complexity Plan eligibility Trends and future developments  – Financing hospitals –
Trends and future developments – Number of hospitals needed –  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Questions and discussion
Other information ,[object Object],[object Object],[object Object],[object Object],[object Object]

Más contenido relacionado

La actualidad más candente

Session 2 a discussion of mary o'mahony paper in session 2a 25 august
Session 2 a discussion of mary o'mahony paper in session 2a 25 augustSession 2 a discussion of mary o'mahony paper in session 2a 25 august
Session 2 a discussion of mary o'mahony paper in session 2a 25 august
IARIW 2014
 

La actualidad más candente (18)

% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
 
Regulation and competition in light of digitalisation – US Federal Trade Comm...
Regulation and competition in light of digitalisation – US Federal Trade Comm...Regulation and competition in light of digitalisation – US Federal Trade Comm...
Regulation and competition in light of digitalisation – US Federal Trade Comm...
 
Sustainability and transition - Maris Jesse, Estonia
Sustainability and transition - Maris Jesse, EstoniaSustainability and transition - Maris Jesse, Estonia
Sustainability and transition - Maris Jesse, Estonia
 
Single Payer Universal Health Insurance 10 24 09
Single Payer Universal Health Insurance 10 24 09Single Payer Universal Health Insurance 10 24 09
Single Payer Universal Health Insurance 10 24 09
 
Tuomas Pöysti: Freedom of choice and competition - How will Finland use it?
Tuomas Pöysti: Freedom of choice and competition - How will Finland use it?Tuomas Pöysti: Freedom of choice and competition - How will Finland use it?
Tuomas Pöysti: Freedom of choice and competition - How will Finland use it?
 
Advanced health technologies and budgetary implications -- Valerie Paris, OECD
Advanced health technologies and budgetary implications -- Valerie Paris, OECDAdvanced health technologies and budgetary implications -- Valerie Paris, OECD
Advanced health technologies and budgetary implications -- Valerie Paris, OECD
 
Prof. Martin Gaynor: Competition in Health Care and Health Insurance - Lesson...
Prof. Martin Gaynor: Competition in Health Care and Health Insurance - Lesson...Prof. Martin Gaynor: Competition in Health Care and Health Insurance - Lesson...
Prof. Martin Gaynor: Competition in Health Care and Health Insurance - Lesson...
 
Prof. Carol Propper: Lessons from experiments in competition and choice in he...
Prof. Carol Propper: Lessons from experiments in competition and choice in he...Prof. Carol Propper: Lessons from experiments in competition and choice in he...
Prof. Carol Propper: Lessons from experiments in competition and choice in he...
 
Johan van Manen, Netherlands Healthcare Authority
Johan van Manen, Netherlands Healthcare AuthorityJohan van Manen, Netherlands Healthcare Authority
Johan van Manen, Netherlands Healthcare Authority
 
Session 2 a discussion of mary o'mahony paper in session 2a 25 august
Session 2 a discussion of mary o'mahony paper in session 2a 25 augustSession 2 a discussion of mary o'mahony paper in session 2a 25 august
Session 2 a discussion of mary o'mahony paper in session 2a 25 august
 
Designing Publicly Funded Healthcare Markets – FELS – November 2018 OECD disc...
Designing Publicly Funded Healthcare Markets – FELS – November 2018 OECD disc...Designing Publicly Funded Healthcare Markets – FELS – November 2018 OECD disc...
Designing Publicly Funded Healthcare Markets – FELS – November 2018 OECD disc...
 
Δρ. Εμμανουήλ Αλεξανδράκης, 3rd Health Innovation Conference
Δρ. Εμμανουήλ Αλεξανδράκης, 3rd Health Innovation ConferenceΔρ. Εμμανουήλ Αλεξανδράκης, 3rd Health Innovation Conference
Δρ. Εμμανουήλ Αλεξανδράκης, 3rd Health Innovation Conference
 
Evaluation of health technologies in France: from theory to practice
Evaluation of health technologies in France: from theory to practice Evaluation of health technologies in France: from theory to practice
Evaluation of health technologies in France: from theory to practice
 
Designing Publicly Funded Healthcare Markets – HARTMAN – November 2018 OECD d...
Designing Publicly Funded Healthcare Markets – HARTMAN – November 2018 OECD d...Designing Publicly Funded Healthcare Markets – HARTMAN – November 2018 OECD d...
Designing Publicly Funded Healthcare Markets – HARTMAN – November 2018 OECD d...
 
What can we learn from other countries?
What can we learn from other countries?What can we learn from other countries?
What can we learn from other countries?
 
The EU Directive of cross-border healthcare - surface and reality
The EU Directive of cross-border healthcare - surface and realityThe EU Directive of cross-border healthcare - surface and reality
The EU Directive of cross-border healthcare - surface and reality
 
Dynamic Efficiency and Value-Based Differential Pricing: Setting Optimal Pri...
Dynamic Efficiency and Value-Based Differential Pricing: Setting Optimal Pri...Dynamic Efficiency and Value-Based Differential Pricing: Setting Optimal Pri...
Dynamic Efficiency and Value-Based Differential Pricing: Setting Optimal Pri...
 
Health Technology Assessment (HTA): a tool for evidence-informed decision mak...
Health Technology Assessment (HTA): a tool for evidence-informed decision mak...Health Technology Assessment (HTA): a tool for evidence-informed decision mak...
Health Technology Assessment (HTA): a tool for evidence-informed decision mak...
 

Similar a Healthcare insurance model in the Netherlands

1115 aine carroll clinical leaders forum nhc integrated care turning healthca...
1115 aine carroll clinical leaders forum nhc integrated care turning healthca...1115 aine carroll clinical leaders forum nhc integrated care turning healthca...
1115 aine carroll clinical leaders forum nhc integrated care turning healthca...
investnethealthcare
 
Presentatie Leers Augustus 2007 Tbv Chinese Delegation Jppc
Presentatie Leers Augustus 2007 Tbv Chinese Delegation JppcPresentatie Leers Augustus 2007 Tbv Chinese Delegation Jppc
Presentatie Leers Augustus 2007 Tbv Chinese Delegation Jppc
marusjkalestrade
 
Insight Guide 2 - Politics & Economics
Insight Guide 2 - Politics & EconomicsInsight Guide 2 - Politics & Economics
Insight Guide 2 - Politics & Economics
Sarah Sanders
 
Professor Michael Chernew: Payment reform, competition and integration
Professor Michael Chernew: Payment reform, competition and integrationProfessor Michael Chernew: Payment reform, competition and integration
Professor Michael Chernew: Payment reform, competition and integration
Nuffield Trust
 
DHL_LSH_Europe_Whitepaper_MedicalDevices_Web
DHL_LSH_Europe_Whitepaper_MedicalDevices_WebDHL_LSH_Europe_Whitepaper_MedicalDevices_Web
DHL_LSH_Europe_Whitepaper_MedicalDevices_Web
Ian Moore
 
Integrating Financing Schemes to Achieve Universal Coverage in Thailand: Anal...
Integrating Financing Schemes to Achieve Universal Coverage in Thailand:Anal...Integrating Financing Schemes to Achieve Universal Coverage in Thailand:Anal...
Integrating Financing Schemes to Achieve Universal Coverage in Thailand: Anal...
CREHS
 

Similar a Healthcare insurance model in the Netherlands (20)

Darragh fahey draft v1
Darragh fahey draft v1Darragh fahey draft v1
Darragh fahey draft v1
 
1115 aine carroll clinical leaders forum nhc integrated care turning healthca...
1115 aine carroll clinical leaders forum nhc integrated care turning healthca...1115 aine carroll clinical leaders forum nhc integrated care turning healthca...
1115 aine carroll clinical leaders forum nhc integrated care turning healthca...
 
2013 Navigate-cost containment in West Australian healthcare-our perspective
2013 Navigate-cost containment in West Australian healthcare-our perspective2013 Navigate-cost containment in West Australian healthcare-our perspective
2013 Navigate-cost containment in West Australian healthcare-our perspective
 
Financing Of Hong Kongs Healthcare
Financing Of Hong Kongs HealthcareFinancing Of Hong Kongs Healthcare
Financing Of Hong Kongs Healthcare
 
Minute Interview: Value Based Procurement
Minute Interview: Value Based ProcurementMinute Interview: Value Based Procurement
Minute Interview: Value Based Procurement
 
Presentatie Leers Augustus 2007 Tbv Chinese Delegation Jppc
Presentatie Leers Augustus 2007 Tbv Chinese Delegation JppcPresentatie Leers Augustus 2007 Tbv Chinese Delegation Jppc
Presentatie Leers Augustus 2007 Tbv Chinese Delegation Jppc
 
Incentivising Competition Health Care in Norway
Incentivising Competition Health Care in NorwayIncentivising Competition Health Care in Norway
Incentivising Competition Health Care in Norway
 
Insight Guide 2 - Politics & Economics
Insight Guide 2 - Politics & EconomicsInsight Guide 2 - Politics & Economics
Insight Guide 2 - Politics & Economics
 
Professor Michael Chernew: Payment reform, competition and integration
Professor Michael Chernew: Payment reform, competition and integrationProfessor Michael Chernew: Payment reform, competition and integration
Professor Michael Chernew: Payment reform, competition and integration
 
Expenditure Management for UHC
Expenditure Management for UHCExpenditure Management for UHC
Expenditure Management for UHC
 
Value based healthcare
Value based healthcareValue based healthcare
Value based healthcare
 
who tanulmány
who tanulmánywho tanulmány
who tanulmány
 
Case study on establishing low cost hospitals in 4 states with low health ind...
Case study on establishing low cost hospitals in 4 states with low health ind...Case study on establishing low cost hospitals in 4 states with low health ind...
Case study on establishing low cost hospitals in 4 states with low health ind...
 
Global telehealth market 2014 2022 sample pages
Global telehealth market 2014 2022 sample pagesGlobal telehealth market 2014 2022 sample pages
Global telehealth market 2014 2022 sample pages
 
DHL_LSH_Europe_Whitepaper_MedicalDevices_Web
DHL_LSH_Europe_Whitepaper_MedicalDevices_WebDHL_LSH_Europe_Whitepaper_MedicalDevices_Web
DHL_LSH_Europe_Whitepaper_MedicalDevices_Web
 
Chris Ham: capitated budgets - a flexible way to enable new models of care
Chris Ham: capitated budgets - a flexible way to enable new models of careChris Ham: capitated budgets - a flexible way to enable new models of care
Chris Ham: capitated budgets - a flexible way to enable new models of care
 
mHealth Israel_Guy Eiferman_Healthcare Services_Merck & Co.
mHealth Israel_Guy Eiferman_Healthcare Services_Merck & Co.mHealth Israel_Guy Eiferman_Healthcare Services_Merck & Co.
mHealth Israel_Guy Eiferman_Healthcare Services_Merck & Co.
 
Top 3 Strategic Initiatives for Sustainable Results in Healthcare in Middle East
Top 3 Strategic Initiatives for Sustainable Results in Healthcare in Middle EastTop 3 Strategic Initiatives for Sustainable Results in Healthcare in Middle East
Top 3 Strategic Initiatives for Sustainable Results in Healthcare in Middle East
 
Integrating Financing Schemes to Achieve Universal Coverage in Thailand: Anal...
Integrating Financing Schemes to Achieve Universal Coverage in Thailand:Anal...Integrating Financing Schemes to Achieve Universal Coverage in Thailand:Anal...
Integrating Financing Schemes to Achieve Universal Coverage in Thailand: Anal...
 
Aligning Health Service And ICT Trends
Aligning Health Service And ICT TrendsAligning Health Service And ICT Trends
Aligning Health Service And ICT Trends
 

Healthcare insurance model in the Netherlands

  • 1. Healthcare in the Netherlands Focussed on hospitals Prague, 25 November 2009
  • 2. Agenda Introduction Financing health care in the Netherlands Critical succesfactors for implementing a new system Lessons learned Trends and future developments Questions and discussion
  • 3. Introduction - Current health care costs How to control health care expenditure in coming years? 13,3% 13,1% 13,1% % GDP in the Netherlands PM 6,3% 6,6% % GDP in The Czech Republic Total health care costs in the Netherlands * = preliminary figures 5,8% 4.809 4.545 4.315 Per person (in Euros) 6,2% 79.091 74.446 70.533 Total 0,4% 2.505 2.494 2.327 Administrative 5,7% 30.204 28.562 27.523 Cure 6,9% 46.382 43.390 40.683 Care ∆ 07/08 2008* 2007* 2006 in millions of Euros
  • 4.
  • 5.
  • 6. Financing health care in the Netherlands – in general – Health Care providers Health care insurers Risk Equalisation Government Policyholders Hospitals Etc. Employers Contribution Contribution Fees Premiums Personal contributions Tax Allowances Cure Settlements Government compensates for budget overruns
  • 7. Financing health care in the Netherlands – hospitals Registration of primary activities and insight into cost prices of products are essential Financing guaranteed by the government Market prices negotiated with health insurance companies Budget based Based on market prices 2004 2020 2012 Parameters related to medical activities Parameters (30,000) based on fee for service model Parameters (3,000) based on fee for service model
  • 8.
  • 9.
  • 10.
  • 11. Trends and future developments – Measuring Quality – Distribution of hospitals in terms of ‘quality of care’. The blue mark indicates the percentage of hospitals performing less good than hospital X
  • 12. University General practitioners Personal health care Elective non-complex care Specialized clinics Process oriented Market prices Basic hospital care Rural hospitals Compliants oriented Performance-related funding Elective very complex care University Medical Centers and large hospitals Process oriented Licensed care and prices Top preference care University Medical Centers Disease oriented Performance-related funding and an academic surcharge Complexity Plan eligibility Trends and future developments – Financing hospitals –
  • 13.
  • 15.